Proellex 50 mg

DRUG5 trials

Sponsors

Repros Therapeutics Inc.

Conditions

AnemiaEndometriosisUterine Fibroids

Phase 2

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

TerminatedNCT00556075

Repros Therapeutics Inc.Endometriosis

Start: 2007-11-30End: 2009-07-31Updated: 2014-08-25

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

TerminatedNCT00683917

Repros Therapeutics Inc.Uterine Fibroids

Start: 2008-05-31End: 2009-08-31Updated: 2014-08-21

Phase 3

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

TerminatedNCT00702702

Repros Therapeutics Inc.Anemia, Uterine Fibroids

Start: 2008-06-30End: 2009-08-31Updated: 2014-08-21

Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids

TerminatedNCT00737282

Repros Therapeutics Inc.Uterine Fibroids

Start: 2008-10-31End: 2009-08-31Updated: 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

TerminatedNCT00785356

Repros Therapeutics Inc.Anemia, Uterine Fibroids

Start: 2008-10-31End: 2009-08-31Updated: 2014-08-21